首页> 外国专利> Bispecific antibody targeting human p185 and vascular endothelial growth factor and application thereof

Bispecific antibody targeting human p185 and vascular endothelial growth factor and application thereof

机译:靶向人P185的双特异性抗体和血管内皮生长因子及其应用

摘要

A bispecific antibody that simultaneously targets humanized p185 and VEGF, consisting of the four peptide chains: two identical antibody light chains that are the light chains of the antibody that identify the epitope or antigen of p185, and two identical antibody heavy chains that have the amino acid sequence of a recombinant antibody from N- to C-terminus, a light chain sequence of the antibody that recognizes the p185 epitope or the antigen; a constant heavy chain region; a flexible short peptide sequence; and either a single-stranded variable region sequence (ScFv) of anti-VEGF antibody which recognizes the VEGF epitope or antigen, or a receptor domain sequence that binds to VEGF. The bispecific antibody has the ability to bind p185 and VEGF at the same time, inhibits the proliferation of tumor cells, and promotes the expression of IFN-γ by T lymphocytes; it may be applied as anti-tumor antibody drug.
机译:同时靶向人源化P185和VEGF的双特异性抗体,由四个肽链组成:两个相同的抗体光链,其是鉴定P185的表位或抗原的抗体的轻链,以及具有氨基的两个相同的抗体重链来自N-至C-末端的重组抗体的酸序列,识别P185表位或抗原的抗体的轻链序列;一个恒定的重链区域;柔性短肽序列;抗VEGF抗体的单链可变区序列(SCFV),其识别VEGF表位或抗原,或与VEGF结合的受体结构域序列。双特异性抗体同时具有结合P185和VEGF的能力,抑制肿瘤细胞的增殖,并通过T淋巴细胞促进IFN-γ的表达;它可以应用为抗肿瘤抗体药物。

著录项

  • 公开/公告号US10973916B2

    专利类型

  • 公开/公告日2021-04-13

    原文格式PDF

  • 申请/专利权人 SUN-BIO MEDICAL DEVICE CO. LTD.;

    申请/专利号US201715854645

  • 发明设计人 YANG YANG;WEI YIN;

    申请日2017-12-26

  • 分类号C07K16/22;C07K16/32;A61K39/395;A61P35;C12N15/79;

  • 国家 US

  • 入库时间 2022-08-24 18:11:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号